Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence H Price

Showing results (11-20 of 132) with videos related to

Pageof 14
Sort By:
Psychiatry Research|October 1, 2018
Time-lagged predictors of daily medication nonadherence beliefs during the month post-hospital discharge in patients with psychotic-spectrum disordersBrandon A Gaudiano, Stacy Ellenberg, Lawrence H Price, et al.
Biological Psychiatry|March 9, 2010
In Reply to: Childhood Maltreatment and Hypothalamic-Pituitary-Adrenal Axis ReactivityAudrey R Tyrka, Lawrence H Price, Linda L Carpenter, et al.
Journal of Psychiatric Practice|January 24, 2008
Augmentation of antidepressants with atypical antipsychotics: a review of the current literatureNoah S Philip, Linda L Carpenter, Audrey R Tyrka, et al.
Depression and Anxiety|July 3, 2007
Sex differences in the use of coping strategies: predictors of anxiety and depressive symptomsMegan M Kelly, Audrey R Tyrka, Lawrence H Price, et al.
Psychopharmacology|July 9, 2010
Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literatureNoah S Philip, Linda L Carpenter, Audrey R Tyrka, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 18, 2003
Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disordersGerard J Marek, Linda L Carpenter, Christopher J McDougle, et al.
Thescientificworldjournal|May 24, 2012
The nicotinic acetylcholine receptor as a target for antidepressant drug developmentNoah S Philip, Linda L Carpenter, Audrey R Tyrka, et al.
Expert Opinion on Pharmacotherapy|February 16, 2010
Pharmacologic approaches to treatment resistant depression: a re-examination for the modern eraNoah S Philip, Linda L Carpenter, Audrey R Tyrka, et al.
Psychopharmacology|January 13, 2011
Gene-environment interactions: early life stress and risk for depressive and anxiety disordersNicole R Nugent, Audrey R Tyrka, Linda L Carpenter, et al.
Medicine and Health, Rhode Island|June 13, 2006
Biomarkers in the human stress system: do they signal risk for depression?Audrey R Tyrka, Linda L Carpenter, John P Carvalho, et al.
Pageof 14

Showing results (11-20 of 132) with videos related to

Sort By:
Pageof 14
Psychiatry Research|October 1, 2018
Time-lagged predictors of daily medication nonadherence beliefs during the month post-hospital discharge in patients with psychotic-spectrum disordersBrandon A Gaudiano, Stacy Ellenberg, Lawrence H Price, et al.
Biological Psychiatry|March 9, 2010
In Reply to: Childhood Maltreatment and Hypothalamic-Pituitary-Adrenal Axis ReactivityAudrey R Tyrka, Lawrence H Price, Linda L Carpenter, et al.
Journal of Psychiatric Practice|January 24, 2008
Augmentation of antidepressants with atypical antipsychotics: a review of the current literatureNoah S Philip, Linda L Carpenter, Audrey R Tyrka, et al.
Depression and Anxiety|July 3, 2007
Sex differences in the use of coping strategies: predictors of anxiety and depressive symptomsMegan M Kelly, Audrey R Tyrka, Lawrence H Price, et al.
Psychopharmacology|July 9, 2010
Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literatureNoah S Philip, Linda L Carpenter, Audrey R Tyrka, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 18, 2003
Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disordersGerard J Marek, Linda L Carpenter, Christopher J McDougle, et al.
Thescientificworldjournal|May 24, 2012
The nicotinic acetylcholine receptor as a target for antidepressant drug developmentNoah S Philip, Linda L Carpenter, Audrey R Tyrka, et al.
Expert Opinion on Pharmacotherapy|February 16, 2010
Pharmacologic approaches to treatment resistant depression: a re-examination for the modern eraNoah S Philip, Linda L Carpenter, Audrey R Tyrka, et al.
Psychopharmacology|January 13, 2011
Gene-environment interactions: early life stress and risk for depressive and anxiety disordersNicole R Nugent, Audrey R Tyrka, Linda L Carpenter, et al.
Medicine and Health, Rhode Island|June 13, 2006
Biomarkers in the human stress system: do they signal risk for depression?Audrey R Tyrka, Linda L Carpenter, John P Carvalho, et al.
Pageof 14